drugset / Trial / NCT06463132
Phase 1b Clinical Trial to Evaluate PEP and EUFLEXXA for Knee Osteoarthritis (KOA)
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluate the safety and exploratory efficacy of single intra-articular injections of PEP reconstituted with 0.9% Normal Saline at a low dose (one vial PEP) and high dose (two vials PEP), with and without EUFLEXXA, for the treatment of Knee Osteoarthritis
Timeline
- Start
- 2024-11-01
- Primary completion
- 2025-11-01
- Completion
- 2025-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hyaluronic Acid | Other / unclassified | — | Other |
| Subject | PEP | Other / unclassified | — | Other |
| Subject | PEP | Other / unclassified | — | Other |